Acacia Research sub inks license agreement with Quest Software
Developer and licenser of patented technologies Acacia Research Corp. (Nasdaq:ACTG) said this morning that its Diagnostic Systems subsidiary made a license agreement with Quest Software, Inc. covering a portfolio of patents that apply to rule-based monitoring. The company also said that the agreement resolves a dispute that was pending in the District Court for the Central District of California. Shares climbed 9.3%, or $0.53, to $6.25 in pre-market trading.
For detailed price information and recent news stories about Acacia Research, click ACTG.
